Dec 13 (Reuters) - Sigma Healthcare Ltd (SIG) :
- ANTICIPATED FY20 EBITDA OF APPROXIMATELY $46 MLN-47 MLN
- GROWTH THROUGH FY21 IS EXPECTED TO ACCELERATE FROM BOTH CORE BUSINESS AND MC/CW GROUP
- SIGMA HEALTHCARE-NEW FIRST-LINE AGREEMENT WITH MY CHEMIST WILL RESULT IN CO ANNUALISED SALES RISING BY $700 - $800 MILLION AT FULL RUN RATE
News: SIG Sigma Healthcare Sees FY20 EBITDA Of About $46 Mln-47 Mln
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.99 |
Change
0.000(0.00%) |
Mkt cap ! $34.51B | |||
| Open | High | Low | Value | Volume |
| $2.96 | $2.99 | $2.96 | $4.299M | 1.447M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 42 | 149450 | $2.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.99 | 135789 | 40 |
View Market Depth
| Last trade - 10.43am 11/09/2025 (20 minute delay) ? |
| SIG (ASX) Chart |